Results 1 - 5 of 7 for: "RiaSTAP"
Refine your search:

RiaSTAP
RiaSTAP is a man-made form of a protein that occurs naturally in the body and helps the blood clot. RiaSTAP is used to treat bleeding episodes in people who have a congenital fibrinogen deficiency. RiaSTAP may also be used for other purposes not listed in this medication guide.
Consumer Information (Drugs.com) · More like this · Add to my drug list

RiaSTAP
RiaSTAP is used for: Treating bleeding in patients with congenital fibrinogen deficiency (eg, afibrinogenemia, hypofibrinogenemia).
Consumer Information (MedFacts) · More like this · Add to my drug list

RiaSTAP
The most serious adverse reactions that have been reported in clinical studies or through postmarketing surveillance following RiaSTAP treatment are allergic-anaphylactic reactions and thromboembolic episodes, including myocardial infarction, pulmonary embolism, deep vein thrombosis, and arterial...
Professional Monographs (FDA) · More like this · Add to my drug list

Fibrinogen Concentrate (Human)
Fibrinogen Concentrate (Human) Pronunciation: (fye-BRIN-oh-jen) Class: Hematologic agent Trade Names: RiaSTAP - Injection, lyophilized powder for solution 900 to 1,300 mg (approximately 1 g) Pharmacology Fibrinogen is a physiological substrate of the 3...
A-Z Drug Facts (Facts & Comparisons) · More like this · Add to my drug list

Riastap Approved for Rare Blood Disorder
FRIDAY, Jan. 16 -- The U.S. Food and Drug Administration has approved Riastap to treat a blood disorder caused by a rare genetic condition. The disorder, congenital fibrinogen deficiency (CFD), affects only 150 to 300 people...
News & Articles (Drugs.com) · More like this

See also: Congenital Fibrinogen Deficiency

Having trouble finding what you want?


MedNotes
Advertisement

(web3)